Drug Discovery Solutions
-
TARGATT™ CHO Cells: Rapid, Stable CHO Cell Generation For Bioproduction
9/30/2025
With our proprietary TARGATT™ technology for site-specific integration of large DNA fragments, we’ve developed a series of TARGATT™ “master” cell lines, including engineered CHO.
-
Mammalian High-Throughput Production
6/5/2026
The demand for high-throughput antibodies has exponentially increased over the last couple of years and has rapidly accelerated the antibody screening process.
-
Small Molecules Discovery
5/28/2026
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.
-
NanoAssemblr® Spark™: Freedom To Discover
4/14/2022
The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.
-
Biologics Discovery
5/28/2026
Make the most of your molecule with integrated antibody discovery, engineering, and production capabilities designed to accelerate lead identification and optimization.
-
HEK293 Transient Production (Tuna293® Process)
6/5/2026
HEK293 cells have been the most popular mammalian transient production platform. The primary advantage of HEK293 cells is transfection efficiency.
-
CHO Transient Production (TunaCHO® Process)
6/5/2026
CHO cells have been the workhorse for protein and antibody manufacturing. The major advantages of CHO include robust growth, hardiness in suspension culture, stellar protein production and secretion, and a long track record.
-
Hybridoma Services
6/5/2026
Curia’s in vivo Discovery Immunology team offers high-performance hybridoma-based technologies to help clients discover great antibodies that make a difference.
-
Meet MaruXTM: Setting The Standard For End-To-End Continuous Biomanufacturing
5/13/2026
Continuous biomanufacturing boosts speed, flexibility, and control. Modular automation, intensified processing, and streamlined workflows drive productivity and consistent quality.
-
Expediting Drug Discovery From Concept To Commercialization
8/13/2024
Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.